About the Journal

Download [This article belongs to Volume - 140, Issue - 02]

Abstract : Hepatitis C virus (HCV) infection is one of the infectious problems in patients undergo hemodialysis (HD) management of end-stage renal disease. Hepatitis C virus infection is considered as the most common chronic liver diseases in patient on (HD). The objective of this study is to determine the prevalence of HCV by antibody testing among patients diagnosed with CKD on regular (HD) from January 2019 to December 2021, and identifications of major risk factors that can increase the risk of hepatitis C in those patients, undergo (HD), by standard questionnaire including the age, gender, the number of blood transfusions patients had received, frequency and the duration of dialysis. An observational cross-sectional study was carried out for the determination of the hepatitis C prevalence in (284) patients diagnosed as chronic kidney disease on hemodialysis in ALAMAL HAEMODIALYSIS CENTER in AL MUTHANNA GOVERNATE & the data was obtained from information in patients ‘medical records.

Copyright © 2020 All rights reserved | Bulletin of National Institute of Health Sciences